Cargando…
Plants as a Source of Anticancer Agents: From Bench to Bedside
Cancer is the second leading cause of death after cardiovascular diseases. Conventional anticancer therapies are associated with lack of selectivity and serious side effects. Cancer hallmarks are biological capabilities acquired by cancer cells during neoplastic transformation. Targeting multiple ca...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369847/ https://www.ncbi.nlm.nih.gov/pubmed/35956766 http://dx.doi.org/10.3390/molecules27154818 |
_version_ | 1784766600987017216 |
---|---|
author | Talib, Wamidh H. Daoud, Safa Mahmod, Asma Ismail Hamed, Reem Ali Awajan, Dima Abuarab, Sara Feras Odeh, Lena Hisham Khater, Samar Al Kury, Lina T. |
author_facet | Talib, Wamidh H. Daoud, Safa Mahmod, Asma Ismail Hamed, Reem Ali Awajan, Dima Abuarab, Sara Feras Odeh, Lena Hisham Khater, Samar Al Kury, Lina T. |
author_sort | Talib, Wamidh H. |
collection | PubMed |
description | Cancer is the second leading cause of death after cardiovascular diseases. Conventional anticancer therapies are associated with lack of selectivity and serious side effects. Cancer hallmarks are biological capabilities acquired by cancer cells during neoplastic transformation. Targeting multiple cancer hallmarks is a promising strategy to treat cancer. The diversity in chemical structure and the relatively low toxicity make plant-derived natural products a promising source for the development of new and more effective anticancer therapies that have the capacity to target multiple hallmarks in cancer. In this review, we discussed the anticancer activities of ten natural products extracted from plants. The majority of these products inhibit cancer by targeting multiple cancer hallmarks, and many of these chemicals have reached clinical applications. Studies discussed in this review provide a solid ground for researchers and physicians to design more effective combination anticancer therapies using plant-derived natural products. |
format | Online Article Text |
id | pubmed-9369847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93698472022-08-12 Plants as a Source of Anticancer Agents: From Bench to Bedside Talib, Wamidh H. Daoud, Safa Mahmod, Asma Ismail Hamed, Reem Ali Awajan, Dima Abuarab, Sara Feras Odeh, Lena Hisham Khater, Samar Al Kury, Lina T. Molecules Review Cancer is the second leading cause of death after cardiovascular diseases. Conventional anticancer therapies are associated with lack of selectivity and serious side effects. Cancer hallmarks are biological capabilities acquired by cancer cells during neoplastic transformation. Targeting multiple cancer hallmarks is a promising strategy to treat cancer. The diversity in chemical structure and the relatively low toxicity make plant-derived natural products a promising source for the development of new and more effective anticancer therapies that have the capacity to target multiple hallmarks in cancer. In this review, we discussed the anticancer activities of ten natural products extracted from plants. The majority of these products inhibit cancer by targeting multiple cancer hallmarks, and many of these chemicals have reached clinical applications. Studies discussed in this review provide a solid ground for researchers and physicians to design more effective combination anticancer therapies using plant-derived natural products. MDPI 2022-07-27 /pmc/articles/PMC9369847/ /pubmed/35956766 http://dx.doi.org/10.3390/molecules27154818 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Talib, Wamidh H. Daoud, Safa Mahmod, Asma Ismail Hamed, Reem Ali Awajan, Dima Abuarab, Sara Feras Odeh, Lena Hisham Khater, Samar Al Kury, Lina T. Plants as a Source of Anticancer Agents: From Bench to Bedside |
title | Plants as a Source of Anticancer Agents: From Bench to Bedside |
title_full | Plants as a Source of Anticancer Agents: From Bench to Bedside |
title_fullStr | Plants as a Source of Anticancer Agents: From Bench to Bedside |
title_full_unstemmed | Plants as a Source of Anticancer Agents: From Bench to Bedside |
title_short | Plants as a Source of Anticancer Agents: From Bench to Bedside |
title_sort | plants as a source of anticancer agents: from bench to bedside |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369847/ https://www.ncbi.nlm.nih.gov/pubmed/35956766 http://dx.doi.org/10.3390/molecules27154818 |
work_keys_str_mv | AT talibwamidhh plantsasasourceofanticanceragentsfrombenchtobedside AT daoudsafa plantsasasourceofanticanceragentsfrombenchtobedside AT mahmodasmaismail plantsasasourceofanticanceragentsfrombenchtobedside AT hamedreemali plantsasasourceofanticanceragentsfrombenchtobedside AT awajandima plantsasasourceofanticanceragentsfrombenchtobedside AT abuarabsaraferas plantsasasourceofanticanceragentsfrombenchtobedside AT odehlenahisham plantsasasourceofanticanceragentsfrombenchtobedside AT khatersamar plantsasasourceofanticanceragentsfrombenchtobedside AT alkurylinat plantsasasourceofanticanceragentsfrombenchtobedside |